FDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
Green Valley Drugs is recalling Acetylcysteine Injection vials because the pharmacy could not ensure the products were sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or property damage risks, specifically involving sterility assurance failures in injectable drugs.
Plain-English summary
The U.S. Food and Drug Administration has issued a recall for Acetylcysteine Injection, including 100 mg/mL in 30 mL vials and 200 mg/mL in 30 mL and 50 mL vials. The product is prescribed only and was compounded, repackaged, and distributed by FVS Holdings, Inc. dba. Green Valley Drugs in Henderson, Nevada.
The recall was initiated due to a lack of assurance of sterility for all sterile products handled by the compounding pharmacy. The FDA cited concerns associated with the facility's quality control processes that prevented verification that the products were sterile.
The recall covers 93 vials distributed nationwide. Specific lot numbers include 20130129-J and 20130129-L (expiring 04/29/13) and 20130405-H (expiring 07/05/13). Patients and healthcare providers should stop using the recalled product and contact their healthcare provider for further instructions.
The recalled product
- Product
- Acetylcysteine Injection, all strengths and all presentations including 100 mg/mL in 30 mL vials and 200 mg/mL in 30 mL and 50 mL vials, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Affected units
- 93
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 20130129-J
- 20130129-L
- Exp 04/29/13
- 20130405-H
- Exp 07/05/13.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Magnesium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereAcetylcysteine Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- CriticalGreen Valley Drugs Recalls Cyanocobalamin Injection Due to Sterility Failure
FDA (Drugs) · 2013-05-22
- SeverePharm D Solutions Recalls Acetylcysteine Injection Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereBeacon Hill Medical Pharmacy Recalls Acetylcysteine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- HighFDA Recalls Fentanyl Injectable for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- SevereSandoz Recalls L-Cysteine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2016-11-23